Peripheral Stent

Related by string. peripheral stent * peripherals . PERIPHERAL . Peripherals . peripheral : peripheral vascular disease . peripheral nerve . peripheral vascular . peripheral vision . worsening peripheral neuropathy . peripheral arterial disease / stenting . Stents . Stenting . stented . stents : drug coated stents . stents inserted . Endeavor stent . Valiant Thoracic Stent Graft . drug coated stent * *

Related by context. Frequent words. (Click for all words.) 68 Announces FDA Clearance 67 Pivotal Trial 66 Completes Enrollment 64 Coronary Stent 64 CE Marked 64 Receives FDA Clearance 64 Phase III Clinical Trial 64 Pivotal Phase III 64 Stent System 63 Phase III Trial 63 Clinical Trial Results 63 FDA Clears 63 Patient Enrollment 62 Zilver PTX 62 Significantly Improves 62 Pivotal Study 61 Initiates Phase II 61 Irinotecan 61 Generic Version 61 drug eluting coronary stent 60 Receives CE 60 Patients Treated 60 Initiate Phase 60 Single Dose 60 FDA Clearance 60 Pivotal Phase 60 TAXUS Liberte 60 Drug Eluting Stent 60 Aloxi R 60 Cardiac Resynchronization Therapy 60 Chronic Hepatitis C 59 Tacrolimus 59 Study Demonstrates 59 Commences Phase 59 cardiovascular restenosis 59 Heart Failure Patients 59 Drug Candidate 59 Coronary Stent System 59 carotid stent 59 Carotid 58 Presents Positive 58 Patients Undergoing 58 Pulmonary Arterial Hypertension 58 Amrubicin 58 Microspheres 58 Ranexa R 58 Pediatric Patients 57 NeuroStar TMS Therapy 57 Ixempra 57 Post Operative 57 Patent Issued 57 Evicel 57 Renal Cell Carcinoma 57 PROMUS 57 FDA Approves 57 drug eluting stent DES 57 Bone Graft 57 Nexavar ® 57 Resection 57 MyoCell 57 Gastric Cancer 56 Testim R 56 Metastatic Colorectal Cancer 56 Clevudine 56 Radiosurgery 56 Elderly Patients 56 Stenting 56 Advanced Prostate Cancer 56 CryoSeal FS System 56 R sorafenib tablets 56 mTOR inhibitor 56 ThermoDox R 56 Non Invasive 56 Metastatic Melanoma 56 Well Tolerated 55 TAXUS Liberte stent 55 REPEL CV 55 Announces Initiation 55 Release Tablets 55 Receives Regulatory 55 Daclizumab 55 Surgical Ablation System 55 patients undergoing percutaneous 55 Combination Therapy 55 Prostate Cancer Treatment 54 II Clinical Trial 54 VALSTAR 54 Anticoagulation 54 MitraClip R 54 Benign Prostatic Hyperplasia 54 Argatroban 54 k Clearance 54 liposomal formulation 54 Preclinical Data 54 Phase Ib II 54 Diabetic Patients 54 Angiox 54 Vandetanib 54 Esophageal 54 undergoing coronary angioplasty 54 Clinical Outcomes

Back to home page